| Home |
| About ISG |
| About influenza |
| Vaccinations |
| Treatments |
| Influenza resources |
| Links |
| Media |
| News |
| Sponsors |
 |
We comply with the HONcode standard for trustworthy health information: verify here. |
| TGA Approves Australian avian influenza vaccine |
|
|
June 2008An Australian-developed and manufactured avian influenza vaccine has received TGA approval in Australia. The TGA announced on 17 June that it had approved the licence for Panvax, manufactured by CSL, for use in the prevention of influenza caused by a pandemic strain of the avian influenza virus. "The vaccine, Panvax, protects humans against the H5N1 influenza virus, which has been responsible for outbreaks of avian influenza in Asia, the Middle East, Europe and Africa," Health Minister Nicola Roxon said in a statement. Three randomised, double-blind clinical studies were conducted to assess the safety of the vaccine in adults aged 18-64, and older adults aged 65 years and over, Roxon said. The vaccine, is administered in two doses and can only be used once an influenza pandemic has been officially declared by the World Health Organisation. Content Updated (Wednesday, 9 July) |